Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1995 | 03-1995 | 12-1994 | 09-1994 | 06-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 680 | 210 | 0 | 4,720 | 5,190 |
| Marketable Securities | 0 | 0 | 5,060 | 0 | 0 |
| Receivables | 10,110 | 9,580 | 7,710 | 10,920 | 5,270 |
| Inventories | 4,130 | 4,450 | 4,450 | 4,210 | 2,690 |
| Other current assets | 2,980 | 2,900 | 3,270 | 2,760 | 880 |
| TOTAL | $17,900 | $17,140 | $20,490 | $22,610 | $14,030 |
| Non-Current Assets | |||||
| Investments And Advances | 250 | 250 | 0 | 80 | 80 |
| TOTAL | $250 | $250 | $0 | $80 | $80 |
| Total Assets | $19,910 | $19,100 | $22,250 | $23,960 | $15,310 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 90 | 140 | 190 | 180 | 70 |
| Other current liabilities | 0 | 0 | 60 | 700 | 0 |
| TOTAL | $6,820 | $6,260 | $8,420 | $10,550 | $2,490 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9 | 10 | 0 | 20 | 30 |
| TOTAL | $9 | $10 | $0 | $20 | $30 |
| Total Liabilities | $6,829 | $6,270 | $8,420 | $10,570 | $2,520 |
| Shareholders' Equity | |||||
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | 360 | 110 | 1,100 | 660 | -20 |
| Other shareholders' equity | 4 | 4 | 4 | 4 | -6 |
| TOTAL | $13,080 | $12,830 | $13,820 | $13,380 | $12,790 |
| Total Liabilities And Equity | $19,909 | $19,100 | $22,240 | $23,950 | $15,310 |